New research reveals that existing USPSTF guidelines may overgeneralize preeclampsia risk, highlighting the need for biologically based, personalized screening methods to improve maternal outcomes.
Thomas McElrath, MD, PhD
Advertisement
Thomas McElrath, MD, PhD, is the vice president of clinical development at Mirvie.
Articles by Thomas McElrath, MD, PhD
Advertisement
Latest Updated Articles
Thomas McElrath, MD, PhD, highlights limitations of current preeclampsia guidelinesPublished: July 17th 2025 | Updated:
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Birth defect risk not impacted by COVID-19 vaccination
2
Breakthrough endometriosis test detects biomarker in menstrual blood
3
Eve Zaritsky, MD, highlights improved oral contraceptive access from e-visits
4
Contemporary OB/GYN week in review: birth complications, fasting, and more
5
